Adocia Launches Phase IIa Clinical Trial for its Ultra-fast Acting Formulation of Analog Insulin

News   Jan 07, 2014

 
Adocia Launches Phase IIa Clinical Trial for its Ultra-fast Acting Formulation of Analog Insulin
 
 
 
FURTHER INFORMATION
 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 
 

Comments | 0 ADD COMMENT